Poly(ADP-Ribose) Polymerase Inhibitor [EPC]

Poly(ADP-Ribose) Polymerase Inhibitor [EPC] was reported 24331 times

Drugs of the Poly(ADP-Ribose) Polymerase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CARBOHYDRATE ANTIGEN 125 INCREASED 1747 0.6250
1 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS 36 0.5070
2 CARBOHYDRATE ANTIGEN 125 8 0.5000
3 ACUTE ERYTHROID LEUKAEMIA 12 0.4138
4 OVARIAN CANCER RECURRENT 321 0.3943
5 BRCA2 GENE MUTATION 19 0.3725
6 BRCA1 GENE MUTATION 9 0.2308
7 RECURRENT CANCER 552 0.2011
8 SCAN ABNORMAL 43 0.1799
9 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 132 0.1774
10 POSITRON EMISSION TOMOGRAM ABNORMAL 69 0.1725
11 LYMPHANGIOLEIOMYOMATOSIS 15 0.1724
12 DRUG MONITORING PROCEDURE NOT PERFORMED 197 0.1660
13 LYMPH NODES SCAN ABNORMAL 14 0.1474
14 LIVER SCAN ABNORMAL 18 0.1374
15 TUMOUR MARKER ABNORMAL 27 0.1189
16 INTENTIONAL UNDERDOSE 653 0.1107
17 TUMOUR MARKER INCREASED 335 0.1024
18 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 43 0.0982
19 FLUID REPLACEMENT 21 0.0972
20 TUMOUR MARKER DECREASED 10 0.0935
21 OVARIAN CANCER METASTATIC 56 0.0854
22 COMPUTERISED TOMOGRAM ABNORMAL 142 0.0728
23 MALIGNANT PERITONEAL NEOPLASM 30 0.0654
24 CORONAVIRUS TEST POSITIVE 49 0.0640
25 METASTASES TO ABDOMINAL CAVITY 24 0.0633
26 WHITE COAT HYPERTENSION 17 0.0630
27 PELVIC NEOPLASM 16 0.0611
28 OVARIAN CANCER STAGE III 17 0.0561
29 INTESTINAL METASTASIS 10 0.0515
30 MEAN CELL HAEMOGLOBIN INCREASED 52 0.0506
31 RED BLOOD CELL COUNT DECREASED 1073 0.0499
32 METASTASES TO PELVIS 21 0.0494
33 OVARIAN CANCER STAGE IV 17 0.0489
34 URETERAL STENT INSERTION 10 0.0452
35 MEAN CELL VOLUME ABNORMAL 16 0.0452
36 METASTASES TO PERITONEUM 78 0.0449
37 MEAN CELL VOLUME INCREASED 73 0.0427
38 DECREASED ACTIVITY 313 0.0415
39 PRODUCT DOSE OMISSION IN ERROR 256 0.0412
40 BLAST CELLS PRESENT 16 0.0411
41 PLATELET COUNT DECREASED 3085 0.0386
42 ABDOMINAL NEOPLASM 27 0.0377
43 TUMOUR COMPRESSION 9 0.0369
44 NEUTROPHIL PERCENTAGE DECREASED 14 0.0365
45 FULL BLOOD COUNT ABNORMAL 187 0.0360
46 BLOOD CREATINE ABNORMAL 12 0.0356
47 RED BLOOD CELL COUNT ABNORMAL 36 0.0351
48 PRODUCT MONITORING ERROR 35 0.0343
49 ABDOMINAL CAVITY DRAINAGE 12 0.0337
50 PELVIC MASS 22 0.0337
51 MYELODYSPLASTIC SYNDROME 379 0.0329
52 BLOOD MAGNESIUM DECREASED 203 0.0324
53 CENTRAL VENOUS CATHETER REMOVAL 11 0.0317
54 MALIGNANT NEOPLASM PROGRESSION 2179 0.0305
55 METASTASES TO SPLEEN 10 0.0301
56 BLOOD COUNT ABNORMAL 469 0.0300
57 METASTASES TO STOMACH 9 0.0298
58 OVARIAN CANCER 221 0.0290
59 MALIGNANT ASCITES 17 0.0285
60 RED CELL DISTRIBUTION WIDTH INCREASED 81 0.0283
61 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 9 0.0283
62 TASTE DISORDER 258 0.0274
63 NEOPLASM RECURRENCE 67 0.0265
64 METASTASES TO PLEURA 18 0.0260
65 ACUTE MYELOID LEUKAEMIA 301 0.0258
66 ACQUIRED GENE MUTATION 23 0.0252
67 CARBOHYDRATE ANTIGEN 19-9 INCREASED 9 0.0250
68 PLATELET DISORDER 46 0.0248
69 NEAR DEATH EXPERIENCE 39 0.0228
70 FAECES HARD 57 0.0216
71 SARS-COV-2 TEST NEGATIVE 10 0.0216
72 HORMONE-REFRACTORY PROSTATE CANCER 16 0.0216
73 PHOTOSENSITIVITY REACTION 274 0.0214
74 RED BLOOD CELL ABNORMALITY 16 0.0213
75 CARBOHYDRATE ANTIGEN 15-3 INCREASED 10 0.0213
76 COLOSTOMY 29 0.0212
77 CONSTIPATION 3220 0.0208
78 METASTASES TO LYMPH NODES 97 0.0207
79 FULL BLOOD COUNT DECREASED 289 0.0206
80 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 9 0.0206
81 PLATELET COUNT ABNORMAL 87 0.0204
82 HAEMATOCRIT DECREASED 337 0.0202
83 MYELOSUPPRESSION 168 0.0201
84 ASPIRATION PLEURAL CAVITY 13 0.0201
85 MEAN PLATELET VOLUME DECREASED 11 0.0195
86 PERITONEAL DISORDER 10 0.0189
87 SOCIAL PROBLEM 60 0.0189
88 RENAL FUNCTION TEST ABNORMAL 59 0.0189
89 PERFORMANCE STATUS DECREASED 70 0.0188
90 HOSPICE CARE 114 0.0184
91 LABORATORY TEST ABNORMAL 405 0.0182
92 HAEMOGLOBIN DECREASED 1467 0.0181
93 INTRA-ABDOMINAL FLUID COLLECTION 21 0.0180
94 FOOD AVERSION 18 0.0174
95 ABDOMINAL LYMPHADENOPATHY 10 0.0171
96 METASTASIS 89 0.0171
97 FLUID INTAKE REDUCED 59 0.0168
98 LARGE INTESTINAL OBSTRUCTION 25 0.0160
99 LYMPHANGIOSIS CARCINOMATOSA 13 0.0159
100 HEPATIC NEOPLASM 41 0.0157
101 HAEMATOTOXICITY 94 0.0156
102 CORONAVIRUS INFECTION 65 0.0155
103 INCISIONAL HERNIA 17 0.0152
104 BONE MARROW DISORDER 34 0.0152
105 GLOMERULAR FILTRATION RATE DECREASED 117 0.0150
106 ABDOMINAL MASS 29 0.0149
107 METASTASES TO LIVER 192 0.0148
108 MASTECTOMY 18 0.0148
109 APPETITE DISORDER 66 0.0148
110 BLOOD PRESSURE INCREASED 1730 0.0147
111 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 9 0.0146
112 HERNIA REPAIR 28 0.0143
113 WHITE BLOOD CELL COUNT DECREASED 1158 0.0143
114 NEUTROPHIL COUNT DECREASED 393 0.0140
115 ACUTE LEUKAEMIA 19 0.0140
116 HEPATIC LESION 44 0.0139
117 NEUROPATHY PERIPHERAL 928 0.0138
118 CANCER SURGERY 9 0.0136
119 BLOOD TEST ABNORMAL 132 0.0136
120 PETECHIAE 110 0.0135
121 PELVIC DISCOMFORT 10 0.0135
122 THYROID HORMONES INCREASED 9 0.0135
123 BLOOD UREA ABNORMAL 9 0.0135
124 HAEMOGLOBIN ABNORMAL 60 0.0134
125 BLOOD ELECTROLYTES DECREASED 13 0.0134
126 METASTASES TO CENTRAL NERVOUS SYSTEM 116 0.0131
127 TRANSFUSION REACTION 9 0.0131
128 MALIGNANT PLEURAL EFFUSION 17 0.0130
129 INTESTINAL OBSTRUCTION 347 0.0129
130 MACROCYTOSIS 12 0.0126
131 TERMINAL INSOMNIA 13 0.0126
132 PLATELET TRANSFUSION 11 0.0126
133 BLOOD PRESSURE DIASTOLIC INCREASED 39 0.0124
134 RETCHING 200 0.0124
135 MEAN CELL HAEMOGLOBIN DECREASED 16 0.0124
136 HEPATIC MASS 17 0.0124
137 TRANSFUSION 102 0.0123
138 HEART RATE INCREASED 931 0.0123
139 ANAEMIA 1827 0.0122
140 BOWEL MOVEMENT IRREGULARITY 62 0.0120
141 FULL BLOOD COUNT INCREASED 10 0.0119
142 DISEASE PROGRESSION 964 0.0118
143 ADVERSE DRUG REACTION 706 0.0118
144 METASTASES TO MENINGES 17 0.0118
145 GASTROINTESTINAL WALL THICKENING 11 0.0117
146 ABDOMINAL HERNIA 43 0.0117
147 BLOOD CREATINE INCREASED 40 0.0117
148 NAIL GROWTH ABNORMAL 10 0.0117
149 ILEUS 107 0.0115
150 THROMBOCYTOPENIA 959 0.0115
151 BLAST CELL COUNT INCREASED 9 0.0114
152 BIOPSY 8 0.0113
153 BLOOD PRESSURE FLUCTUATION 212 0.0112
154 SUNBURN 69 0.0112
155 ENERGY INCREASED 54 0.0112
156 MIDDLE INSOMNIA 153 0.0111
157 PRODUCT DOSE OMISSION ISSUE 1216 0.0111
158 NAIL DISCOLOURATION 33 0.0111
159 PHARYNGEAL ULCERATION 11 0.0111
160 ASCITES 253 0.0110
161 TUMOUR PAIN 11 0.0110
162 DRY MOUTH 667 0.0109
163 TONGUE DISCOMFORT 31 0.0109
164 PRODUCT DIFFICULT TO SWALLOW 11 0.0108
165 BONE MARROW TOXICITY 13 0.0108
166 GASTROINTESTINAL MOTILITY DISORDER 41 0.0107
167 HAEMATOCRIT ABNORMAL 10 0.0107
168 REFLUX GASTRITIS 9 0.0107
169 CATHETER MANAGEMENT 9 0.0106
170 BLOOD CREATININE ABNORMAL 26 0.0106
171 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 11 0.0104
172 NEOPLASM PROGRESSION 270 0.0104
173 SMALL INTESTINAL OBSTRUCTION 96 0.0103
174 HAIR GROWTH ABNORMAL 56 0.0103
175 BLOOD CREATININE INCREASED 535 0.0103
176 WHITE BLOOD CELL COUNT ABNORMAL 47 0.0102
177 MILIARIA 12 0.0102
178 INSOMNIA 2161 0.0102
179 STOMATITIS 451 0.0102
180 NODULE 98 0.0101
181 DECREASED APPETITE 1687 0.0100
182 BLOOD CREATININE DECREASED 23 0.0100
183 RED BLOOD CELL COUNT INCREASED 19 0.0095
184 UPPER-AIRWAY COUGH SYNDROME 54 0.0095
185 COLONOSCOPY 15 0.0094
186 ILEOSTOMY 14 0.0094
187 EMERGENCY CARE 15 0.0093
188 METASTASES TO LUNG 77 0.0093
189 GASTROINTESTINAL STOMA COMPLICATION 11 0.0093
190 RENAL IMPAIRMENT 571 0.0092
191 ORAL PAIN 163 0.0092
192 ANAEMIA MACROCYTIC 15 0.0092
193 CANCER PAIN 16 0.0091
194 BLOOD PRESSURE ABNORMAL 123 0.0089
195 SLEEP DISORDER 439 0.0089
196 CARCINOEMBRYONIC ANTIGEN INCREASED 12 0.0089
197 ERUCTATION 110 0.0089
198 PULMONARY MASS 95 0.0088
199 FEEDING DISORDER 108 0.0088
200 LYMPHOEDEMA 44 0.0087
201 WHITE BLOOD CELL DISORDER 18 0.0087
202 BLOOD POTASSIUM DECREASED 203 0.0087
203 PROSTATIC SPECIFIC ANTIGEN INCREASED 92 0.0086
204 NAUSEA 5187 0.0086
205 INITIAL INSOMNIA 63 0.0086
206 STENT PLACEMENT 57 0.0086
207 BLOOD CHLORIDE DECREASED 19 0.0085
208 SUBILEUS 15 0.0085
209 GLYCOSYLATED HAEMOGLOBIN DECREASED 9 0.0085
210 METASTASES TO BONE 95 0.0085
211 ILLNESS 288 0.0084
212 PROSTATE CANCER METASTATIC 21 0.0083
213 BONE MARROW FAILURE 151 0.0082
214 EARLY SATIETY 12 0.0081
215 DYSPNOEA EXERTIONAL 216 0.0080
216 GINGIVAL BLEEDING 79 0.0080
217 BLOOD IRON DECREASED 63 0.0080
218 BLOOD SODIUM DECREASED 116 0.0080
219 FATIGUE 4565 0.0079
220 DENTAL CARE 11 0.0079
221 ABDOMINAL RIGIDITY 16 0.0079
222 PIGMENTATION DISORDER 36 0.0078
223 NEUTROPHIL COUNT ABNORMAL 15 0.0075
224 PANCYTOPENIA 313 0.0075
225 LIP PAIN 17 0.0075
226 HERNIA 105 0.0075
227 CYTOPENIA 49 0.0074
228 METASTATIC NEOPLASM 24 0.0074
229 ORAL MUCOSAL BLISTERING 37 0.0074
230 NEOPLASM 62 0.0074
231 THYROID MASS 19 0.0074
232 DYSPEPSIA 538 0.0073
233 TRIGGER FINGER 21 0.0073
234 VOLVULUS 12 0.0073
235 NAIL DISORDER 42 0.0073
236 HEART RATE ABNORMAL 29 0.0073
237 CHANGE OF BOWEL HABIT 12 0.0071
238 INFREQUENT BOWEL MOVEMENTS 13 0.0071
239 VITAMIN B12 DECREASED 14 0.0070
240 ILL-DEFINED DISORDER 221 0.0070
241 MONOCYTE COUNT INCREASED 18 0.0069
242 BLOOD UREA INCREASED 99 0.0069
243 RENAL MASS 11 0.0069
244 MOTION SICKNESS 10 0.0068
245 METASTASES TO SPINE 16 0.0068
246 LYMPHADENOPATHY 182 0.0067
247 FLATULENCE 286 0.0067
248 POOR QUALITY SLEEP 104 0.0067
249 ONYCHOCLASIS 33 0.0067
250 GENE MUTATION 9 0.0067
251 HYPERTENSION 1040 0.0065
252 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 186 0.0065
253 CARDIAC FLUTTER 32 0.0064
254 PAROSMIA 37 0.0064
255 NOCTURIA 55 0.0063
256 INTENTIONAL DOSE OMISSION 58 0.0063
257 PNEUMONITIS 118 0.0063
258 DENTAL OPERATION 10 0.0062
259 DRUG TOLERANCE DECREASED 10 0.0062
260 TONGUE DISCOLOURATION 24 0.0062
261 UNDERDOSE 345 0.0062
262 GASTRIC INFECTION 17 0.0062
263 HYDRONEPHROSIS 35 0.0061
264 FRUSTRATION TOLERANCE DECREASED 33 0.0061
265 INTERSTITIAL LUNG DISEASE 213 0.0060
266 HOT FLUSH 318 0.0060
267 BREAST CANCER RECURRENT 14 0.0060
268 BLOOD BLISTER 15 0.0060
269 BLOOD DISORDER 37 0.0060
270 MOUTH HAEMORRHAGE 33 0.0059
271 DRY THROAT 46 0.0059
272 ABDOMINAL DISCOMFORT 729 0.0059
273 INCREASED TENDENCY TO BRUISE 44 0.0059
274 TONGUE BLISTERING 11 0.0059
275 PRODUCT USE COMPLAINT 44 0.0059
276 MACULE 12 0.0059
277 REGURGITATION 15 0.0059
278 CONTUSION 426 0.0059
279 PROTEIN URINE PRESENT 22 0.0058
280 SECOND PRIMARY MALIGNANCY 37 0.0058
281 ASTHENIA 1666 0.0058
282 DYSCHEZIA 10 0.0058
283 MASS 64 0.0057
284 SEASONAL ALLERGY 51 0.0057
285 TUMOUR HAEMORRHAGE 12 0.0057
286 BLADDER SPASM 8 0.0057
287 FAECES SOFT 23 0.0056
288 OROPHARYNGEAL DISCOMFORT 29 0.0056
289 DIZZINESS POSTURAL 36 0.0056
290 ABDOMINAL ADHESIONS 15 0.0055
291 ABDOMINAL DISTENSION 431 0.0055
292 BRAIN NEOPLASM 38 0.0055
293 URINE ANALYSIS ABNORMAL 14 0.0055
294 BLOOD IRON INCREASED 8 0.0054
295 PARANASAL SINUS DISCOMFORT 13 0.0054
296 BONE LESION 15 0.0054
297 FOOD CRAVING 15 0.0053
298 DYSGEUSIA 319 0.0053
299 VITAMIN D DECREASED 36 0.0053
300 VOMITING 1883 0.0053
301 PRODUCT DOSE OMISSION 353 0.0053
302 ANIMAL BITE 10 0.0053
303 APHTHOUS ULCER 24 0.0052
304 SINUS DISORDER 77 0.0052
305 SENSITIVITY OF TEETH 9 0.0052
306 BONE PAIN 238 0.0052
307 THIRST 64 0.0051
308 GASTROINTESTINAL OBSTRUCTION 9 0.0051
309 PALPITATIONS 461 0.0051
310 PRODUCT DISTRIBUTION ISSUE 12 0.0051
311 DEHYDRATION 537 0.0051
312 URINE ODOUR ABNORMAL 24 0.0051
313 PULMONARY THROMBOSIS 41 0.0051
314 TACHYPHRENIA 14 0.0050
315 OBSTRUCTION 13 0.0050
316 BLOOD PRESSURE SYSTOLIC INCREASED 72 0.0050
317 BLOOD CALCIUM INCREASED 35 0.0050
318 FAECALOMA 20 0.0050
319 EATING DISORDER 83 0.0050
320 HAEMORRHAGE URINARY TRACT 10 0.0050
321 INGROWING NAIL 9 0.0049
322 PLATELET COUNT INCREASED 48 0.0049
323 TEMPERATURE INTOLERANCE 36 0.0049
324 DEATH 3126 0.0049
325 ABDOMINAL INFECTION 9 0.0049
326 ABDOMINAL PAIN UPPER 741 0.0048
327 HOSPITALISATION 481 0.0048
328 PHARYNGEAL SWELLING 24 0.0048
329 DRUG INTOLERANCE 328 0.0048
330 BILE DUCT OBSTRUCTION 9 0.0047
331 LEUKAEMIA 34 0.0047
332 GASTROINTESTINAL TOXICITY 14 0.0047
333 CREATININE RENAL CLEARANCE DECREASED 16 0.0046
334 GASTROINTESTINAL SOUNDS ABNORMAL 15 0.0046
335 SURGERY 176 0.0046
336 FOOD INTOLERANCE 12 0.0046
337 NIGHT SWEATS 107 0.0046
338 LIP DRY 23 0.0046
339 HAEMOGLOBIN INCREASED 13 0.0046
340 MUSCULOSKELETAL DISCOMFORT 59 0.0046
341 SECRETION DISCHARGE 37 0.0045
342 PNEUMOCYSTIS JIROVECII PNEUMONIA 30 0.0045
343 APLASIA PURE RED CELL 12 0.0045
344 ERYTHEMA NODOSUM 11 0.0045
345 BLOOD POTASSIUM INCREASED 57 0.0044
346 HEART RATE IRREGULAR 84 0.0044
347 AGEUSIA 86 0.0044
348 TONGUE ULCERATION 12 0.0044
349 FUNCTIONAL GASTROINTESTINAL DISORDER 12 0.0044
350 SARS-COV-2 TEST POSITIVE 36 0.0044
351 RENAL DISORDER 157 0.0044
352 RESTLESS LEGS SYNDROME 63 0.0043
353 RHINORRHOEA 198 0.0043
354 LYMPHOCYTE COUNT INCREASED 10 0.0043
355 GLOSSITIS 12 0.0043
356 HUNGER 34 0.0043
357 MULTIPLE ALLERGIES 23 0.0042
358 FOOD POISONING 15 0.0042
359 VITAMIN B12 DEFICIENCY 12 0.0042
360 MUSCLE FATIGUE 13 0.0042
361 GASTROINTESTINAL PAIN 33 0.0042
362 PRODUCT USE IN UNAPPROVED INDICATION 612 0.0042
363 ORAL DISORDER 24 0.0042
364 SPONDYLITIS 10 0.0042
365 HORDEOLUM 10 0.0041
366 BALANCE DISORDER 282 0.0041
367 GASTROOESOPHAGEAL REFLUX DISEASE 247 0.0041
368 STRESS 212 0.0040
369 URINE ABNORMALITY 13 0.0040
370 FEELING JITTERY 64 0.0040
371 THERAPY CHANGE 23 0.0040
372 PLEURAL EFFUSION 194 0.0040
373 WEIGHT DECREASED 852 0.0040
374 PERIPHERAL COLDNESS 43 0.0040
375 FLANK PAIN 29 0.0040
376 THYROID DISORDER 46 0.0040
377 ARTHROPOD BITE 22 0.0040
378 HEAD DISCOMFORT 50 0.0040
379 EMOTIONAL DISTRESS 423 0.0040
380 GINGIVAL PAIN 24 0.0039
381 ABDOMINAL PAIN LOWER 79 0.0039
382 SENSITIVE SKIN 16 0.0039
383 OROPHARYNGEAL PAIN 265 0.0039
384 LYMPHOCYTE COUNT DECREASED 52 0.0039
385 BACK PAIN 692 0.0039
386 COGNITIVE DISORDER 136 0.0038
387 DYSPHAGIA 271 0.0038
388 PARANASAL SINUS HYPERSECRETION 12 0.0038
389 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 329 0.0038
390 GLOSSODYNIA 59 0.0038
391 OFF LABEL USE 1945 0.0038
392 ABDOMINAL TENDERNESS 15 0.0038
393 HEPATIC CYST 10 0.0038
394 HEADACHE 1809 0.0037
395 CATARACT OPERATION 17 0.0037
396 ONYCHOMADESIS 9 0.0037
397 MUSCULOSKELETAL CHEST PAIN 44 0.0037
398 LIMB DISCOMFORT 86 0.0037
399 PAPULE 16 0.0037
400 ABNORMAL FAECES 22 0.0037
401 URINARY TRACT INFECTION 459 0.0037
402 BLOOD ALKALINE PHOSPHATASE INCREASED 76 0.0036
403 FEELING ABNORMAL 710 0.0036
404 WALKING AID USER 17 0.0036
405 NEURALGIA 64 0.0036
406 VULVOVAGINAL DRYNESS 9 0.0036
407 B-CELL LYMPHOMA 10 0.0036
408 TEMPOROMANDIBULAR JOINT SYNDROME 9 0.0035
409 MYALGIA 467 0.0035
410 SLUGGISHNESS 28 0.0035
411 HEPATIC ENZYME ABNORMAL 13 0.0035
412 SUSPECTED COVID-19 9 0.0035
413 BRUXISM 15 0.0035
414 SKIN DISCOLOURATION 125 0.0035
415 PERIPHERAL SWELLING 379 0.0035
416 EPISTAXIS 205 0.0035
417 BLOOD URINE PRESENT 53 0.0035
418 CANDIDA INFECTION 40 0.0035
419 HAEMORRHAGE SUBCUTANEOUS 10 0.0034
420 TOOTH EXTRACTION 34 0.0034
421 ARTHRALGIA 1006 0.0034
422 DISEASE COMPLICATION 12 0.0034
423 PROTEIN TOTAL DECREASED 10 0.0034
424 SINUS HEADACHE 17 0.0034
425 NERVOUSNESS 151 0.0034
426 TEARFULNESS 12 0.0034
427 DYSPHONIA 148 0.0034
428 ABDOMINAL PAIN 597 0.0034
429 DIZZINESS 1282 0.0033
430 SALIVARY HYPERSECRETION 25 0.0033
431 ORAL DISCOMFORT 36 0.0033
432 MUSCLE STRAIN 22 0.0033
433 SUPRAVENTRICULAR TACHYCARDIA 25 0.0032
434 MICTURITION DISORDER 9 0.0032
435 FAILURE TO THRIVE 14 0.0032
436 SCIATICA 34 0.0032
437 MUCOSAL INFLAMMATION 63 0.0032
438 BLOOD CHOLESTEROL ABNORMAL 11 0.0032
439 NERVE COMPRESSION 22 0.0032
440 HYPOMAGNESAEMIA 31 0.0032
441 LIVER FUNCTION TEST INCREASED 43 0.0032
442 NASAL DRYNESS 15 0.0032
443 DRUG RESISTANCE 58 0.0031
444 ELECTROCARDIOGRAM ABNORMAL 20 0.0031
445 HYPERSOMNIA 68 0.0031
446 GALLBLADDER OPERATION 9 0.0031
447 GAIT INABILITY 60 0.0031
448 BLOOD CHOLESTEROL INCREASED 108 0.0031
449 PSYCHOMOTOR HYPERACTIVITY 43 0.0031
450 TONGUE DISORDER 19 0.0031
451 PROCTALGIA 15 0.0031
452 VITREOUS FLOATERS 21 0.0031
453 FUNGAL SKIN INFECTION 9 0.0030
454 ANXIETY 695 0.0030
455 GASTROENTERITIS VIRAL 39 0.0030
456 THERAPY CESSATION 109 0.0030
457 COUGH 602 0.0030
458 NEUTROPENIA 284 0.0030
459 EMBOLISM 20 0.0030
460 GASTRITIS 62 0.0030
461 SNEEZING 47 0.0030
462 PELVIC PAIN 43 0.0030
463 ENTERITIS 13 0.0030
464 SKIN DISORDER 69 0.0030
465 CHAPPED LIPS 10 0.0029
466 GASTROINTESTINAL INFECTION 19 0.0029
467 KIDNEY INFECTION 43 0.0029
468 RENAL CYST 19 0.0029
469 EPIGASTRIC DISCOMFORT 9 0.0029
470 MALAISE 1013 0.0029
471 CYSTITIS 74 0.0029
472 TENDERNESS 24 0.0029
473 THROMBOSIS 184 0.0029
474 DYSPNOEA 1246 0.0029
475 ARTHRITIS 168 0.0029
476 OESOPHAGEAL DISORDER 9 0.0029
477 CYST 27 0.0029
478 BREAST MASS 15 0.0029
479 TERMINAL STATE 15 0.0029
480 POSTOPERATIVE WOUND INFECTION 14 0.0028
481 PRODUCTIVE COUGH 93 0.0028
482 NASAL DISCOMFORT 18 0.0028
483 GINGIVAL SWELLING 10 0.0028
484 POLLAKIURIA 90 0.0028
485 GLUCOSE TOLERANCE IMPAIRED 12 0.0028
486 RESPIRATION ABNORMAL 13 0.0028
487 HAEMORRHOIDS 43 0.0028
488 PRODUCT PRESCRIBING ISSUE 17 0.0028
489 NEUTROPENIC SEPSIS 16 0.0028
490 INTESTINAL RESECTION 11 0.0028
491 NASAL CONGESTION 113 0.0028
492 HYPOPHAGIA 52 0.0028
493 THYROID FUNCTION TEST ABNORMAL 10 0.0028
494 INCREASED APPETITE 35 0.0028
495 BLOOD CALCIUM DECREASED 25 0.0028
496 THERAPY PARTIAL RESPONDER 14 0.0027
497 EXTRASYSTOLES 16 0.0027
498 IMPAIRED QUALITY OF LIFE 23 0.0027
499 MUSCLE SPASMS 389 0.0027
500 RENAL PAIN 22 0.0027
501 HYPOAESTHESIA 316 0.0027
502 BREAST PAIN 24 0.0027
503 FORMICATION 16 0.0027
504 THERAPY INTERRUPTED 61 0.0027
505 INTENTIONAL PRODUCT MISUSE 175 0.0027
506 GASTROINTESTINAL DISORDER 149 0.0027
507 WHEELCHAIR USER 9 0.0027
508 TOOTH INFECTION 26 0.0027
509 EAR PAIN 39 0.0026
510 MEMORY IMPAIRMENT 281 0.0026
511 HAEMOLYTIC ANAEMIA 19 0.0026
512 SKIN LACERATION 18 0.0026
513 MADAROSIS 28 0.0026
514 HYPERKERATOSIS 11 0.0026
515 COVID-19 224 0.0026
516 BLOOD THYROID STIMULATING HORMONE INCREASED 19 0.0026
517 BREAST CANCER METASTATIC 21 0.0026
518 IMMUNE SYSTEM DISORDER 25 0.0026
519 MUSCULAR WEAKNESS 226 0.0026
520 HEPATIC ENZYME INCREASED 125 0.0026
521 PRODUCT USE ISSUE 342 0.0026
522 ODYNOPHAGIA 11 0.0025
523 HIATUS HERNIA 27 0.0025
524 DYSURIA 74 0.0025
525 NASOPHARYNGITIS 323 0.0025
526 FEELING COLD 54 0.0025
527 HYPERTENSIVE CRISIS 22 0.0025
528 PAIN IN EXTREMITY 573 0.0025
529 HYPERCHLORHYDRIA 13 0.0024
530 PRODUCT SIZE ISSUE 9 0.0024
531 TOOTHACHE 34 0.0024
532 MICTURITION URGENCY 21 0.0024
533 TACHYCARDIA 165 0.0024
534 EMOTIONAL DISORDER 61 0.0024
535 LOCALISED OEDEMA 9 0.0024
536 EAR DISCOMFORT 18 0.0024
537 DIARRHOEA 1123 0.0024
538 DRY EYE 68 0.0024
539 NEPHROPATHY TOXIC 18 0.0024
540 BRAIN NEOPLASM MALIGNANT 9 0.0023
541 LOW DENSITY LIPOPROTEIN INCREASED 13 0.0023
542 INSURANCE ISSUE 11 0.0023
543 CATARACT 98 0.0023
544 CEREBRAL DISORDER 12 0.0023
545 UROSEPSIS 16 0.0023
546 HERPES ZOSTER 101 0.0023
547 FEELING HOT 105 0.0023
548 JOINT STIFFNESS 45 0.0023
549 DISEASE RECURRENCE 60 0.0023
550 SERUM FERRITIN INCREASED 9 0.0022
551 HYPERHIDROSIS 226 0.0022
552 ORAL CANDIDIASIS 21 0.0022
553 TOOTH DISORDER 40 0.0022
554 SPINAL PAIN 19 0.0022
555 PRURITUS 559 0.0022
556 OESOPHAGITIS 19 0.0022
557 RASH PRURITIC 87 0.0022
558 IMMUNODEFICIENCY 20 0.0022
559 LUNG DISORDER 79 0.0022
560 CONDITION AGGRAVATED 443 0.0022
561 ALOPECIA 339 0.0022
562 BLOOD URIC ACID INCREASED 9 0.0022
563 WHITE BLOOD CELL COUNT INCREASED 67 0.0022
564 TOOTH ABSCESS 18 0.0022
565 BACK DISORDER 27 0.0021
566 UNEVALUABLE EVENT 132 0.0021
567 BEDRIDDEN 22 0.0021
568 GAIT DISTURBANCE 322 0.0021
569 LEUKOPENIA 81 0.0021
570 NECK PAIN 91 0.0021
571 OSTEOPENIA 26 0.0021
572 BLOOD BILIRUBIN INCREASED 47 0.0021
573 CARDIAC VALVE DISEASE 10 0.0021
574 INTRACRANIAL PRESSURE INCREASED 9 0.0021
575 THROAT IRRITATION 69 0.0021
576 JOINT INJURY 34 0.0021
577 DEPRESSED MOOD 83 0.0021
578 LIGAMENT SPRAIN 15 0.0021
579 CHEILITIS 9 0.0021
580 EXERCISE TOLERANCE DECREASED 9 0.0021
581 THERAPEUTIC RESPONSE UNEXPECTED 76 0.0021
582 DISCOMFORT 84 0.0021
583 BLOOD ALBUMIN DECREASED 13 0.0021
584 COLITIS 53 0.0021
585 SINUSITIS 157 0.0021
586 CRYING 63 0.0020
587 WRIST FRACTURE 19 0.0020
588 RECTAL HAEMORRHAGE 70 0.0020
589 HERPES VIRUS INFECTION 9 0.0020
590 INFLAMMATION 70 0.0020
591 LETHARGY 92 0.0020
592 GASTRIC DISORDER 65 0.0020
593 TREMOR 265 0.0020
594 NEUTROPHIL COUNT INCREASED 16 0.0020
595 PERICARDIAL EFFUSION 34 0.0020
596 HYPOTHYROIDISM 45 0.0020
597 PULMONARY TOXICITY 9 0.0020
598 LYMPHOMA 24 0.0020
599 HAEMATOCHEZIA 77 0.0020
600 SPINAL OSTEOARTHRITIS 14 0.0020
601 TINNITUS 70 0.0020
602 COLON CANCER 23 0.0020
603 LYMPHOPENIA 20 0.0020
604 HICCUPS 12 0.0020
605 BLOOD GLUCOSE INCREASED 302 0.0020
606 PULMONARY OEDEMA 69 0.0020
607 GLYCOSYLATED HAEMOGLOBIN INCREASED 36 0.0020
608 ADVERSE REACTION 20 0.0020
609 DRY SKIN 178 0.0020
610 SINUS CONGESTION 20 0.0019
611 FEELING OF BODY TEMPERATURE CHANGE 9 0.0019
612 ASPARTATE AMINOTRANSFERASE INCREASED 83 0.0019
613 QUALITY OF LIFE DECREASED 20 0.0019
614 HEAD INJURY 46 0.0019
615 LIVER DISORDER 63 0.0019
616 SCAR 26 0.0019
617 OSTEOPOROSIS 62 0.0019
618 BLOOD GLUCOSE FLUCTUATION 17 0.0019
619 PNEUMONIA BACTERIAL 11 0.0019
620 HIP ARTHROPLASTY 19 0.0019
621 NEOPLASM MALIGNANT 92 0.0019
622 OCULAR DISCOMFORT 12 0.0019
623 RASH 587 0.0019
624 RASH MACULAR 47 0.0019
625 GROIN PAIN 13 0.0018
626 MIGRAINE 126 0.0018
627 CLOSTRIDIUM DIFFICILE INFECTION 28 0.0018
628 PARAESTHESIA 224 0.0018
629 HEPATIC FUNCTION ABNORMAL 49 0.0018
630 SENSATION OF FOREIGN BODY 11 0.0018
631 ALANINE AMINOTRANSFERASE INCREASED 90 0.0018
632 CHEST DISCOMFORT 139 0.0018
633 KNEE OPERATION 11 0.0018
634 MOUTH ULCERATION 28 0.0018
635 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 12 0.0018
636 TENDONITIS 23 0.0018
637 GASTROINTESTINAL INFLAMMATION 10 0.0018
638 ADVERSE EVENT 130 0.0018
639 PHOTOPSIA 9 0.0018
640 ELECTROLYTE IMBALANCE 15 0.0018
641 HYPOKINESIA 21 0.0018
642 URINE OUTPUT DECREASED 13 0.0018
643 POLYNEUROPATHY 15 0.0018
644 PAIN 855 0.0018
645 IRRITABLE BOWEL SYNDROME 26 0.0018
646 BASAL CELL CARCINOMA 21 0.0018
647 VISION BLURRED 182 0.0018
648 IMMUNOSUPPRESSION 10 0.0018
649 ECCHYMOSIS 10 0.0018
650 EXOSTOSIS 12 0.0018
651 ANORECTAL DISCOMFORT 8 0.0018
652 LACRIMATION INCREASED 36 0.0018
653 BLOOD PRESSURE DECREASED 90 0.0018
654 INTESTINAL PERFORATION 15 0.0017
655 DYSSTASIA 40 0.0017
656 ESCHERICHIA INFECTION 10 0.0017
657 EYE INFECTION 13 0.0017
658 SPINAL COMPRESSION FRACTURE 12 0.0017
659 NERVE INJURY 15 0.0017
660 ABNORMAL DREAMS 40 0.0017
661 CHILLS 151 0.0017
662 LARYNGITIS 13 0.0017
663 EAR INFECTION 30 0.0017
664 HAEMATURIA 47 0.0017
665 LIMB INJURY 32 0.0017
666 VIRAL INFECTION 39 0.0017
667 RESTLESSNESS 48 0.0017
668 FEBRILE NEUTROPENIA 78 0.0017
669 CHROMATURIA 30 0.0017
670 VERTIGO 80 0.0017
671 INTERNAL HAEMORRHAGE 15 0.0016
672 ROTATOR CUFF SYNDROME 17 0.0016
673 URINARY RETENTION 42 0.0016
674 HIP FRACTURE 40 0.0016
675 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0016
676 DEAFNESS 32 0.0016
677 BLADDER DISORDER 13 0.0016
678 JOINT SWELLING 142 0.0016
679 MUSCLE TIGHTNESS 21 0.0016
680 TRANSIENT ISCHAEMIC ATTACK 45 0.0016
681 VAGINAL HAEMORRHAGE 59 0.0016
682 LUNG INFECTION 25 0.0016
683 HAEMORRHAGE 125 0.0016
684 HYSTERECTOMY 10 0.0016
685 PROTEINURIA 21 0.0016
686 MUSCULOSKELETAL PAIN 74 0.0016
687 SOMNOLENCE 246 0.0016
688 COLD SWEAT 22 0.0016
689 BURNING SENSATION 87 0.0016
690 DEVICE RELATED INFECTION 20 0.0016
691 LIVER FUNCTION TEST ABNORMAL 40 0.0016
692 RENAL FAILURE 177 0.0016
693 PURPURA 11 0.0015
694 FRACTURE 23 0.0015
695 PULMONARY EMBOLISM 121 0.0015
696 INFLUENZA 114 0.0015
697 EYE PRURITUS 31 0.0015
698 AMNESIA 81 0.0015
699 AUTOIMMUNE DISORDER 8 0.0015
700 FAECES DISCOLOURED 26 0.0015
701 ATRIAL FIBRILLATION 113 0.0015
702 ATELECTASIS 12 0.0015
703 APPENDICITIS 10 0.0015
704 HYPONATRAEMIA 66 0.0015
705 WEIGHT INCREASED 251 0.0015
706 SYNCOPE 118 0.0015
707 CONFUSIONAL STATE 190 0.0015
708 ORAL HERPES 20 0.0015
709 DIVERTICULITIS 31 0.0015
710 GALLBLADDER DISORDER 22 0.0015
711 MYOPATHY 10 0.0015
712 HYPOKALAEMIA 51 0.0015
713 PRESYNCOPE 27 0.0015
714 BACK INJURY 11 0.0015
715 MACULAR DEGENERATION 13 0.0015
716 URINARY INCONTINENCE 34 0.0015
717 UPPER LIMB FRACTURE 24 0.0015
718 SKIN HYPERPIGMENTATION 10 0.0015
719 HYPERAESTHESIA 10 0.0015
720 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0014
721 BLOOD TRIGLYCERIDES INCREASED 21 0.0014
722 BACTERIAL INFECTION 19 0.0014
723 PNEUMOTHORAX 17 0.0014
724 SCAB 12 0.0014
725 PAIN IN JAW 33 0.0014
726 VAGINAL DISCHARGE 12 0.0014
727 POST PROCEDURAL COMPLICATION 22 0.0014
728 VISUAL IMPAIRMENT 126 0.0014
729 FALL 365 0.0014
730 PRODUCT AVAILABILITY ISSUE 12 0.0014
731 BRAIN OEDEMA 14 0.0014
732 INFECTION 146 0.0014
733 CHOLELITHIASIS 37 0.0014
734 VASCULITIS 12 0.0014
735 ANOSMIA 16 0.0014
736 PYREXIA 377 0.0014
737 HAIR TEXTURE ABNORMAL 17 0.0014
738 MUSCULOSKELETAL STIFFNESS 93 0.0014
739 HEPATIC STEATOSIS 20 0.0014
740 PHOTOPHOBIA 19 0.0014
741 FOOT FRACTURE 21 0.0014
742 EYE HAEMORRHAGE 15 0.0014
743 RIB FRACTURE 22 0.0014
744 EYE DISORDER 34 0.0014
745 FREQUENT BOWEL MOVEMENTS 24 0.0014
746 MOVEMENT DISORDER 35 0.0014
747 ATRIAL FLUTTER 9 0.0014
748 DEPRESSION 259 0.0014
749 BODY HEIGHT DECREASED 13 0.0014
750 SQUAMOUS CELL CARCINOMA 10 0.0014
751 PULMONARY FIBROSIS 18 0.0013
752 CENTRAL NERVOUS SYSTEM LESION 16 0.0013
753 SINUS TACHYCARDIA 15 0.0013
754 DRUG ERUPTION 17 0.0013
755 HYPERTHYROIDISM 14 0.0013
756 APHASIA 32 0.0013
757 EPILEPSY 29 0.0013
758 GOUT 18 0.0013
759 FUNGAL INFECTION 33 0.0013
760 HAEMATEMESIS 27 0.0013
761 SPUTUM DISCOLOURED 9 0.0013
762 COMPLICATION ASSOCIATED WITH DEVICE 13 0.0013
763 DRUG-INDUCED LIVER INJURY 24 0.0013
764 APHONIA 13 0.0013
765 MENTAL IMPAIRMENT 25 0.0013
766 CHEST PAIN 194 0.0013
767 SKIN CANCER 21 0.0013
768 OEDEMA 53 0.0013
769 PRODUCT PHYSICAL ISSUE 18 0.0013
770 SPINAL FRACTURE 19 0.0013
771 RETINAL DETACHMENT 9 0.0013
772 INTERVERTEBRAL DISC DEGENERATION 10 0.0013
773 SKIN HAEMORRHAGE 11 0.0013
774 BODY TEMPERATURE INCREASED 21 0.0013
775 BRONCHITIS 75 0.0013
776 GLAUCOMA 19 0.0013
777 TRANSAMINASES INCREASED 22 0.0012
778 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 89 0.0012
779 MOBILITY DECREASED 66 0.0012
780 CHOKING 18 0.0012
781 GENERAL PHYSICAL HEALTH DETERIORATION 97 0.0012
782 BLOOD GLUCOSE DECREASED 49 0.0012
783 MUSCLE ATROPHY 11 0.0012
784 PRODUCT ADMINISTRATION ERROR 14 0.0012
785 MALNUTRITION 10 0.0012
786 HYPOTENSION 189 0.0012
787 ADRENAL INSUFFICIENCY 9 0.0012
788 PARAESTHESIA ORAL 13 0.0012
789 BLISTER 50 0.0012
790 ULCER 15 0.0012
791 SEPSIS 105 0.0012
792 PNEUMONIA 288 0.0012
793 INCONTINENCE 10 0.0012
794 FLUID RETENTION 48 0.0012
795 BACTERAEMIA 10 0.0012
796 PULMONARY CONGESTION 12 0.0012
797 KNEE ARTHROPLASTY 16 0.0012
798 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 21 0.0012
799 ERYTHEMA 187 0.0012
800 RASH ERYTHEMATOUS 37 0.0012
801 HYPERSENSITIVITY 167 0.0012
802 NEPHROLITHIASIS 39 0.0012
803 ARTERIOSCLEROSIS 9 0.0012
804 INTENTIONAL PRODUCT USE ISSUE 66 0.0012
805 HAEMOPTYSIS 26 0.0012
806 RASH PAPULAR 21 0.0012
807 EXTRA DOSE ADMINISTERED 24 0.0011
808 WOUND 21 0.0011
809 MOOD ALTERED 24 0.0011
810 OEDEMA PERIPHERAL 116 0.0011
811 TOXICITY TO VARIOUS AGENTS 137 0.0011
812 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0011
813 DRUG INTERACTION 140 0.0011
814 BLOOD GLUCOSE ABNORMAL 16 0.0011
815 PHARYNGITIS 11 0.0011
816 IMPAIRED HEALING 27 0.0011
817 DISTURBANCE IN ATTENTION 48 0.0011
818 SWOLLEN TONGUE 28 0.0011
819 SPEECH DISORDER 46 0.0011
820 HYPOAESTHESIA ORAL 13 0.0011
821 DRUG INEFFECTIVE 1087 0.0011
822 PROCEDURAL PAIN 22 0.0011
823 HALLUCINATION 60 0.0011
824 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19 0.0011
825 PRODUCT TASTE ABNORMAL 11 0.0011
826 DERMATITIS CONTACT 9 0.0011
827 CHOLECYSTITIS 10 0.0011
828 LEUKOCYTOSIS 15 0.0011
829 PANIC ATTACK 31 0.0011
830 DIPLOPIA 21 0.0011
831 INTERVERTEBRAL DISC PROTRUSION 19 0.0011
832 MENTAL STATUS CHANGES 24 0.0011
833 NIGHTMARE 30 0.0011
834 HAEMATOMA 23 0.0011
835 VENTRICULAR EXTRASYSTOLES 9 0.0011
836 HEPATOTOXICITY 17 0.0011
837 MANIA 14 0.0011
838 RESPIRATORY TRACT INFECTION 19 0.0011
839 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 18 0.0010
840 GASTRIC ULCER 16 0.0010
841 SKIN REACTION 11 0.0010
842 UPPER RESPIRATORY TRACT INFECTION 35 0.0010
843 CARPAL TUNNEL SYNDROME 11 0.0010
844 CARDIAC FAILURE 63 0.0010
845 THINKING ABNORMAL 16 0.0010
846 CEREBRAL HAEMORRHAGE 29 0.0010
847 ARRHYTHMIA 39 0.0010
848 SWELLING 70 0.0010
849 DENTAL CARIES 9 0.0010
850 LIVER INJURY 14 0.0010
851 PRODUCT DISPENSING ERROR 12 0.0010
852 CARDIOMYOPATHY 12 0.0010
853 SKIN LESION 20 0.0010
854 LOCALISED INFECTION 18 0.0010
855 LOSS OF CONSCIOUSNESS 100 0.0010
856 RASH MACULO-PAPULAR 16 0.0010
857 ARTHROPATHY 41 0.0010
858 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0010
859 CELLULITIS 39 0.0010
860 ISCHAEMIC STROKE 14 0.0010
861 PALLOR 19 0.0010
862 HEPATIC FAILURE 23 0.0009
863 CARDIAC DISORDER 71 0.0009
864 INFLUENZA LIKE ILLNESS 64 0.0009
865 FEAR 22 0.0009
866 PRESCRIBED UNDERDOSE 13 0.0009
867 DRUG DOSE OMISSION 153 0.0009
868 DERMATITIS 13 0.0009
869 DISORIENTATION 30 0.0009
870 DEEP VEIN THROMBOSIS 51 0.0009
871 OXYGEN SATURATION DECREASED 35 0.0009
872 APATHY 10 0.0009
873 DIABETES MELLITUS 55 0.0009
874 FIBROMYALGIA 15 0.0009
875 SEIZURE 68 0.0009
876 PRODUCT COMPLAINT 11 0.0009
877 NEUROTOXICITY 10 0.0008
878 ABSCESS 10 0.0008
879 HYPOXIA 22 0.0008
880 SUBDURAL HAEMATOMA 10 0.0008
881 SWELLING FACE 42 0.0008
882 ANKLE FRACTURE 10 0.0008
883 SKIN BURNING SENSATION 47 0.0008
884 OSTEOARTHRITIS 26 0.0008
885 MUSCLE TWITCHING 15 0.0008
886 HEPATIC CANCER 17 0.0008
887 DYSARTHRIA 24 0.0008
888 FLUSHING 68 0.0008
889 PAIN OF SKIN 17 0.0008
890 HYPERGLYCAEMIA 23 0.0008
891 AGRANULOCYTOSIS 10 0.0008
892 HYPERKALAEMIA 21 0.0008
893 PANCREATIC CARCINOMA 19 0.0008
894 DEMENTIA 15 0.0008
895 HEART RATE DECREASED 21 0.0008
896 CEREBROVASCULAR ACCIDENT 107 0.0008
897 ACUTE KIDNEY INJURY 82 0.0008
898 LOWER LIMB FRACTURE 10 0.0008
899 LIP SWELLING 19 0.0007
900 COAGULOPATHY 10 0.0007
901 SENSORY DISTURBANCE 10 0.0007
902 HEPATIC CIRRHOSIS 10 0.0007
903 PRODUCT PRESCRIBING ERROR 10 0.0007
904 INCORRECT DOSE ADMINISTERED 100 0.0007
905 PHARYNGEAL OEDEMA 11 0.0007
906 AGITATION 44 0.0007
907 ENCEPHALOPATHY 13 0.0007
908 THERAPY NON-RESPONDER 19 0.0007
909 ECZEMA 15 0.0007
910 EYE SWELLING 20 0.0007
911 PARANOIA 10 0.0007
912 HYPOACUSIS 21 0.0007
913 ANGINA PECTORIS 17 0.0007
914 TREATMENT NONCOMPLIANCE 26 0.0007
915 URTICARIA 84 0.0007
916 DYSKINESIA 22 0.0007
917 EYE PAIN 26 0.0007
918 IRRITABILITY 34 0.0007
919 ANGER 19 0.0007
920 STAPHYLOCOCCAL INFECTION 18 0.0007
921 ORTHOSTATIC HYPOTENSION 9 0.0007
922 RESPIRATORY FAILURE 38 0.0007
923 MUSCULOSKELETAL DISORDER 10 0.0006
924 BONE DISORDER 10 0.0006
925 HEMIPARESIS 9 0.0006
926 PNEUMONIA ASPIRATION 12 0.0006
927 HYPOCALCAEMIA 9 0.0006
928 ANGIOEDEMA 21 0.0006
929 HEPATITIS 12 0.0006
930 LUNG NEOPLASM MALIGNANT 21 0.0006
931 MOOD SWINGS 16 0.0006
932 SKIN ULCER 12 0.0006
933 PERITONITIS 10 0.0006
934 ASTHMA 43 0.0006
935 SLEEP APNOEA SYNDROME 9 0.0006
936 THROAT TIGHTNESS 12 0.0006
937 BREAST CANCER 48 0.0006
938 SKIN EXFOLIATION 33 0.0006
939 MELAENA 10 0.0006
940 PRURITUS GENERALISED 12 0.0006
941 DELIRIUM 14 0.0006
942 LOWER RESPIRATORY TRACT INFECTION 17 0.0005
943 GASTRIC CANCER 12 0.0005
944 TYPE 2 DIABETES MELLITUS 14 0.0005
945 FEMUR FRACTURE 14 0.0005
946 CARDIOVASCULAR DISORDER 12 0.0005
947 NERVOUS SYSTEM DISORDER 14 0.0005
948 ACUTE MYOCARDIAL INFARCTION 13 0.0005
949 ELECTROCARDIOGRAM QT PROLONGED 14 0.0005
950 WHEEZING 21 0.0005
951 SKIN IRRITATION 19 0.0005
952 RASH GENERALISED 13 0.0005
953 C-REACTIVE PROTEIN INCREASED 13 0.0005
954 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
955 TREATMENT FAILURE 27 0.0005
956 DRUG HYPERSENSITIVITY 73 0.0005
957 GASTROINTESTINAL HAEMORRHAGE 34 0.0005
958 OSTEONECROSIS OF JAW 10 0.0005
959 RESPIRATORY DISTRESS 10 0.0005
960 CHRONIC KIDNEY DISEASE 30 0.0004
961 SEPTIC SHOCK 14 0.0004
962 JAUNDICE 10 0.0004
963 CARDIAC FAILURE CONGESTIVE 32 0.0004
964 PRODUCT STORAGE ERROR 16 0.0004
965 RESPIRATORY DISORDER 10 0.0004
966 MYOCARDIAL INFARCTION 67 0.0004
967 PSYCHOTIC DISORDER 10 0.0004
968 OCULAR HYPERAEMIA 13 0.0004
969 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0004
970 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0004
971 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0004
972 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0004
973 EYE IRRITATION 14 0.0004
974 ACCIDENTAL OVERDOSE 10 0.0004
975 RHABDOMYOLYSIS 12 0.0004
976 BLINDNESS 11 0.0004
977 PANCREATITIS 15 0.0004
978 MENTAL DISORDER 12 0.0004
979 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0003
980 ROAD TRAFFIC ACCIDENT 11 0.0003
981 ACNE 21 0.0003
982 BONE DENSITY DECREASED 9 0.0003
983 GYNAECOMASTIA 9 0.0003
984 SUICIDAL IDEATION 22 0.0003
985 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0003
986 HYPOGLYCAEMIA 11 0.0003
987 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0003
988 PROSTATE CANCER 20 0.0003
989 CARDIO-RESPIRATORY ARREST 9 0.0003
990 MEDICATION ERROR 10 0.0002
991 INJURY 12 0.0002
992 RHEUMATOID ARTHRITIS 15 0.0002
993 OVERDOSE 29 0.0002
994 NO ADVERSE EVENT 18 0.0002
995 CARDIAC ARREST 11 0.0002
996 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
997 PSORIASIS 14 0.0001
998 PRODUCT QUALITY ISSUE 15 0.0001